Drug safety and translational toxicology
8 European H2020 organizations list this as part of their work — 8 as their primary capability.
Most active in this area
- BAYER AKTIENGESELLSCHAFT
Global pharmaceutical company contributing drug safety data, clinical expertise, and AI capabilities to Europe's largest health research consortia.
“Core contributor to eTRANSAFE (computational toxicology, data sharing), IB4SD-TRISTAN (imaging biomarker validation for drug safety), and SAMT (sustainability assessment).”
PrimaryDE59 projects - NOVARTIS PHARMA AG
Global pharmaceutical company contributing clinical data, drug safety expertise, and translational medicine capabilities to large-scale European health research consortia.
“Core contributor to eTRANSAFE (translational safety, computational toxicology), EQIPD (preclinical data quality), WEB-RADR 2, and ADAPT-SMART (regulatory pathways).”
PrimaryCH57 projects - F. HOFFMANN-LA ROCHE AG
Global pharma giant contributing drug safety data, biomarker expertise, and diagnostics capabilities to 45 H2020 health consortia across neuroscience, toxicology, and clinical trials.
“Core contributor to EU-ToxRisk, eTRANSAFE, TransBioLine, imSAVAR, and EQIPD — covering computational toxicology, biomarker qualification, and micro-physiological safety systems.”
PrimaryCH45 projects - SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Sanofi's R&D division contributing pharma-scale drug safety, oncology, and clinical trial expertise across 37 major EU health partnerships.
“TransQST, TransBioLine, NeuroDeRisk, imSAVAR, ConcePTION, and EQIPD all focus on preclinical safety, biomarker qualification, and nonclinical assessment of therapeutics.”
PrimaryFR37 projects - MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
German pharma and materials giant contributing drug safety data, compound libraries, and OLED expertise across 34 H2020 consortia in 39 countries.
“Core contributor to eTRANSAFE (data sharing for safety assessment), imSAVAR (immune safety modeling), MELLODDY (federated learning for drug discovery), ConcePTION (pregnancy pharmacovigilance), and CARE (COVID-19 drug repurposing).”
PrimaryDE34 projects - SANOFI-AVENTIS DEUTSCHLAND GMBH
Global pharma company contributing clinical data, compound libraries, and translational toxicology expertise to European diabetes and immunology research consortia.
“Participated in eTRANSAFE (computational toxicology and data integration), IB4SD-TRISTAN (imaging biomarker validation for drug safety), and contributed toxicology expertise across multiple IMI projects.”
PrimaryDE18 projects - SYNAPSE RESEARCH MANAGEMENT PARTNERS SL
Spanish SME managing operations, data governance, and sustainability for Europe's largest public-private health research consortia.
“Major involvement in eTRANSAFE (EUR 2.85M, their largest grant), TransQST (systems toxicology), and TransBioLine (safety biomarker pipeline).”
PrimarySMEES17 projects - FUNDACIO INSTITUT HOSPITAL DEL MAR D INVESTIGACIONS MEDIQUES
Barcelona hospital-based research institute specializing in drug safety, translational toxicology, biomedical data infrastructure, and neuroscience.
“Coordinated eTRANSAFE (largest project, EUR 1.88M) and participated in TransQST and FAIRplus — all focused on improving drug safety assessment through data integration and systems pharmacology.”
PrimaryES11 projects